Scholarship will fund a 3-year PhD candidature to work in the Cancer, Ageing & Vaccine Laboratory (SHBS). Project is a collaboration with WEHI and Hudson Institute to improve cancer diagnosis, prevention and treatment.
Scholarship will fund a 3-year PhD candidature to work in the Cancer, Ageing & Vaccine Laboratory (SHBS). Project is a collaboration with WEHI and Hudson Institute to improve cancer diagnosis, prevention and treatment.
- The value of the Scholarship is equivalent to an RMIT full Scholarship
- This Scholarship will be available for 3.5 years.
- The value of the Scholarship is equivalent to an RMIT full Scholarship
- This Scholarship will be available for 3.5 years.
Applicants need to have a background in immunology or cancer biology, preferably cancer immunology and most preferably ovarian cancer. They must have completed a relevant Bachelor’s Degree and Honour’s or Master’s. Due to COVID-19 restrictions, applicants must living in Australia at time of application.
Applicants need to have a background in immunology or cancer biology, preferably cancer immunology and most preferably ovarian cancer. They must have completed a relevant Bachelor’s Degree and Honour’s or Master’s. Due to COVID-19 restrictions, applicants must living in Australia at time of application.
Email Distinguished Professor Magdalena Plebanski ([email protected]) directly with their statement of interest, cover letter addressing the desirable criteria, CV and academic qualifications.
Also see the HDR How to Apply website .
Email Distinguished Professor Magdalena Plebanski ([email protected]) directly with their statement of interest, cover letter addressing the desirable criteria, CV and academic qualifications.
Also see the HDR How to Apply website .
Applications are open now.
Applications are open now.
31 December 2023.
31 December 2023.
Three
Three
The Cancer, Ageing and Vaccines Laboratory seeks to understand cancer biology and immune responses and to translate these findings into real-world clinical benefits. As part of this research, the lab runs several clinical trials, such as SOLACE2, which is testing combination chemotherapies for ovarian cancer treatment (Scott et al., 2019, doi.org/10.1111/ajco.13263) and IOCT, which recently identified a key biomarker for diagnosis of ovarian cancer (Kampan et al., 2020, doi: 10.1038/s41598-020-59009-z).
Most recently, is our collaboration with Professor Scott (WEHI) on the Stafford Fox Rare Cancers trial. This trial seeks to understand why people diagnosed with three or more cancers have a much better survival rate than those diagnosed with one or two cancers. The project will study biobanked samples from these "super survivor" individuals to test if they have specific health characteristics, set at just the right level to control or knock out their cancer.
One key goal of these trials is to identify the key functional targets for the immune response and leverage this to initiate development of personalised cancer vaccines. As part of this goal, the PhD candidate could choose to become involved in any number of aspects and Is welcome to discuss ideas and options with Distinguished Professor Magdalena Plebanski.
Across all projects, the PhD Candidate will use techniques such as germline/tumour sequencing data, plasma analysis and work with patients’ immune cells work to identify key functional targets. They may perform epigenetic techniques, DNA sequencing (HLA-typing and WES), transcriptomics and immunoassays such as ELISpots.
Desirable criteria:
- Practical experience and conceptual background in cellular immunology, particularly tumour immunology.
- Practical experience and conceptual background in solid tumour biology, particularly ovarian cancer.
- Interest in, and ability to, work in an interdisciplinary setting including immunologists, cancer biologists, and clinicians.
- Experience in tissue culture.
The Cancer, Ageing and Vaccines Laboratory seeks to understand cancer biology and immune responses and to translate these findings into real-world clinical benefits. As part of this research, the lab runs several clinical trials, such as SOLACE2, which is testing combination chemotherapies for ovarian cancer treatment (Scott et al., 2019, doi.org/10.1111/ajco.13263) and IOCT, which recently identified a key biomarker for diagnosis of ovarian cancer (Kampan et al., 2020, doi: 10.1038/s41598-020-59009-z).
Most recently, is our collaboration with Professor Scott (WEHI) on the Stafford Fox Rare Cancers trial. This trial seeks to understand why people diagnosed with three or more cancers have a much better survival rate than those diagnosed with one or two cancers. The project will study biobanked samples from these "super survivor" individuals to test if they have specific health characteristics, set at just the right level to control or knock out their cancer.
One key goal of these trials is to identify the key functional targets for the immune response and leverage this to initiate development of personalised cancer vaccines. As part of this goal, the PhD candidate could choose to become involved in any number of aspects and Is welcome to discuss ideas and options with Distinguished Professor Magdalena Plebanski.
Across all projects, the PhD Candidate will use techniques such as germline/tumour sequencing data, plasma analysis and work with patients’ immune cells work to identify key functional targets. They may perform epigenetic techniques, DNA sequencing (HLA-typing and WES), transcriptomics and immunoassays such as ELISpots.
Desirable criteria:
- Practical experience and conceptual background in cellular immunology, particularly tumour immunology.
- Practical experience and conceptual background in solid tumour biology, particularly ovarian cancer.
- Interest in, and ability to, work in an interdisciplinary setting including immunologists, cancer biologists, and clinicians.
- Experience in tissue culture.
For further inquiries please contact Distinguished Professor Magdalena Plebanski ([email protected]).
For further inquiries please contact Distinguished Professor Magdalena Plebanski ([email protected]).
Similar Positions
-
Joint Monash Leipzig Ph D Programme In Health: Open Ph D Scholarships In The School Of Chemistry At Monash University, Monash University, Australia, 1 day ago
Joint Monash-Leipzig PhD programme in Health: Open PhD scholarships in the School of Chemistry at Monash University Job No.: 664818 Location: Clayton campus Employment Type: Full-time Duration: 3-...
-
Patricia Stanley Bolch Scholarship, Swinburne University of Technology, Australia, 1 day ago
The Patricia Stanley Bolch Scholarship honors the late Patricia Stanley Bolch. In her quiet and determined demeanour, Patricia understood how profoundly education can change the course of one’s li...
-
Scholarships Manager, University of Melbourne, Australia, about 10 hours ago
Job no: 0062214 Location: Parkville Role type: Full-time; Continuing Department/School: Student and Scholarly Services Salary: UOM 8 - $115,537 - $124,622p.a. plus 17% super Lead scholarship initi...
-
Ph D Scholarship Development Of Heat Flow Monitoring System For The Bof, Swinburne University of Technology, Australia, 1 day ago
Department of Mechanical and Product Design Engineering Full time, fixed term position at our Hawthorn Campus and BlueScope Steel in Port Kembla Stipend of $33,413 p.a. will be offered for the thr...
-
Manager Graduation, Fees And Scholarships, Swinburne University of Technology, Australia, 1 day ago
Prime opportunity to be a leader of student administration services HEW 8, Permanent, Full Time position in a central Hawthorn location Staff benefits include discount study fees and options for h...
-
Ph D Scholarship Ct And Mri Multimodal Segmentation Of The Cochlea And Adjacent Anatomical Structures, University of Melbourne, Australia, about 11 hours ago
The University of Melbourne is a leading international university with over 160 years of experience in teaching and research. Located in the Greater Melbourne Area, the university is committed to ...